从资金流向来看，8月18日主力资金净流出1284.35万元，近五个交易日累计净流出1101.65万元。当前股 价位于五日线和六十日均线之间，市场交投保持平稳态势。 风险提示：投资有风险，入市需谨慎。本文所载信息仅供参考，不构成任何投资建议。 来源：金融界 蓝帆医疗8月18日报收6.13元，较前一交易日下跌0.06元，跌幅0.97%。当日成交量为238594手，成交金 额达1.47亿元。 该公司属于医疗器械板块，主营业务涵盖健康防护手套、心脏介入器械等医疗产品的研发、生产和销 售。作为医疗防护领域的重要企业，其产品广泛应用于医疗检查和防护领域。 据公司最新公告披露，蓝帆医疗及其子公司目前无逾期对外担保情况，也未涉及因担保引发的诉讼纠 纷。这一信息披露有助于投资者了解公司的财务健康状况。 ...

Group 1 - The stock price of Bluestar Medical closed at 6.19 yuan on August 14, 2025, down by 0.14 yuan, representing a decline of 2.21% from the previous trading day [1] - The trading volume on that day was 175,800 hands, with a transaction amount of 110 million yuan [1] - Bluestar Medical's main business includes the medical device sector, with key products such as medical gloves, health protective gloves, and first aid kits [1] Group 2 - On the evening of August 14, Bluestar Medical announced that its sixth board of directors approved a proposal to lower the conversion price of "Bluestar Convertible Bonds" [1] - The same proposal was also approved at the third temporary shareholders' meeting held on August 14 [1] - On August 14, the net inflow of main funds into Bluestar Medical was 4.78 million yuan, but there was a cumulative net outflow of 6.68 million yuan over the past five trading days [1]

蓝帆医疗股份有限公司主要业务是心脑血管业务、健康防护业务及护理业务。公司主要产品包括冠脉植 介入、结构性心脏病以及和心脏介入手术相关的医疗器械产品，健康防护手套，以急救箱包为主的各类 紧急救援产品和一次性健康防护用品。蓝帆医疗是全球PVC健康防护手套行业的龙头企业，PVC健康防 护手套年产销量及市场占有率均为全球第一。 5月19日，蓝帆医疗今日收盘5.31元，上涨1.14%，最新市净率0.66，创47天以来新低，总市值53.48亿 元。 股东方面，截至2025年4月18日，蓝帆医疗股东户数80811户，较上次减少95户，户均持股市值35.28万 元，户均持股数量2.76万股。 序号股票简称PE(TTM)PE(静)市净率总市值(元)21蓝帆医疗-19.83-12.000.6653.48亿行业平均 49.2647.464.56105.99亿行业中值36.7137.322.4947.70亿1天益医疗-1763.34-3020.401.8822.47亿2澳华内 镜-613.48307.694.9164.65亿3诺唯赞-411.11-486.242.2687.98亿4爱朋医疗-367.45279.154.4330.15 ...

Core Viewpoint - Bluefan Medical's stock closed at 4.49 yuan, down 2.39%, with a latest price-to-book ratio of 0.52 and a total market capitalization of 4.522 billion yuan [1] Company Overview - Bluefan Medical Co., Ltd. primarily operates in cardiovascular, health protection, and nursing businesses, with key products including coronary intervention devices, structural heart disease products, health protection gloves, and emergency rescue products [1] - The company is a global leader in the PVC health protection gloves industry, holding the highest annual production and market share [1] Shareholder Information - As of March 31, 2025, Bluefan Medical had 81,034 shareholders, a decrease of 1,123 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Financial Performance - In the latest quarterly report for Q3 2024, the company achieved a revenue of 4.654 billion yuan, representing a year-on-year increase of 29.85%, while the net profit was -219.82 million yuan, a year-on-year decline of 38.19%, with a gross profit margin of 17.17% [1] Valuation Metrics - Bluefan Medical's PE (TTM) is -10.45, PE (static) is -7.96, and the price-to-book ratio is 0.52, with a total market value of 4.522 billion yuan [2]

4月14日，蓝帆医疗今日收盘4.68元，上涨2.63%，最新市净率0.55，总市值47.13亿元。 资金流向方面，4月14日，蓝帆医疗主力资金净流出239.68万元，近5日总体呈流出状态，5日共流出 2073.07万元。 来源：金融界 蓝帆医疗股份有限公司主要业务是心脑血管业务、健康防护业务及护理业务。公司主要产品包括冠脉植 介入、结构性心脏病以及和心脏介入手术相关的医疗器械产品，健康防护手套，以急救箱包为主的各类 紧急救援产品和一次性健康防护用品。蓝帆医疗是全球PVC健康防护手套行业的龙头企业，PVC健康防 护手套年产销量及市场占有率均为全球第一。 最新一期业绩显示，2024年三季报，公司实现营业收入46.54亿元，同比29.85%；净利润-219822842.84 元，同比38.19%，销售毛利率17.17%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)23蓝帆医疗-10.90-8.290.5547.13亿行业平均 45.7149.434.75102.82亿行业中值29.9929.792.3746.97亿1硕世生物-1863.40-1863.401.1738.50亿2诺唯 赞-532.18-5 ...